Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Laika, B; Leucht, S; Heres, S; Steimer, W 
Titel:
Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening? 
Abstract:
The cytochrome P450 2D6 (CYP2D6) isoenzyme metabolizes about 25% of clinically used drugs. The impact of CYP2D6 metabolizer status on therapeutic outcome was assessed in 365 psychiatric in-patients treated with neuroleptics or antidepressants. Length of hospitalization and response onset were prolonged for patients receiving CYP2D6 drugs. Intermediate metabolizers (IMs) receiving CYP2D6 doses above the population median had more side effects after 4 weeks than extensive metabolizers with above-m...    »
 
Zeitschriftentitel:
Pharmacogenomics J 
Jahr:
2009 
Band / Volume:
Heft / Issue:
Seitenangaben Beitrag:
395-403 
Sprache:
eng 
Print-ISSN:
1470-269X 
TUM Einrichtung:
r Klinische Chemie und Pathobiochemie; r Psychiatrie und Psychotherapie